Simian Acquired Immunodeficiency Syndrome
"Simian Acquired Immunodeficiency Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Acquired defect of cellular immunity that occurs naturally in macaques infected with SRV serotypes, experimentally in monkeys inoculated with SRV or MASON-PFIZER MONKEY VIRUS; (MPMV), or in monkeys infected with SIMIAN IMMUNODEFICIENCY VIRUS.
| Descriptor ID |
D016097
|
| MeSH Number(s) |
C02.782.815.616.850 C02.839.850 C22.735.500.850
|
| Concept/Terms |
Simian Acquired Immunodeficiency Syndrome- Simian Acquired Immunodeficiency Syndrome
- Simian AIDS
- Simian Acquired Immuno-Deficiency Syndrome
- Simian Acquired Immuno Deficiency Syndrome
- Simian Acquired Immune Deficiency Syndrome
- AIDS, Simian
- AIDSs, Simian
- Simian AIDSs
- SAIDS
|
Below are MeSH descriptors whose meaning is more general than "Simian Acquired Immunodeficiency Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Simian Acquired Immunodeficiency Syndrome".
This graph shows the total number of publications written about "Simian Acquired Immunodeficiency Syndrome" by people in this website by year, and whether "Simian Acquired Immunodeficiency Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Simian Acquired Immunodeficiency Syndrome" by people in Profiles.
-
Differential V2-directed antibody responses in non-human primates infected with SHIVs or immunized with diverse HIV vaccines. Nat Commun. 2022 02 16; 13(1):903.
-
Infection of Chinese Rhesus Monkeys with a Subtype C SHIV Resulted in Attenuated In Vivo Viral Replication Despite Successful Animal-to-Animal Serial Passages. Viruses. 2021 03 02; 13(3).
-
Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to a4ß7. PLoS Pathog. 2018 08; 14(8):e1007278.
-
Broadly neutralizing antibodies targeting the HIV-1 envelope V2 apex confer protection against a clade C SHIV challenge. Sci Transl Med. 2017 09 06; 9(406).
-
Nonprogressing HIV-infected children share fundamental immunological features of nonpathogenic SIV infection. Sci Transl Med. 2016 09 28; 8(358):358ra125.
-
Specificity of the autologous neutralizing antibody response. Curr Opin HIV AIDS. 2009 Sep; 4(5):358-63.